HRID874873

反应详情

EQUATION

反应方程式

REACTANTS

反应物

HCID6422

未命名化合物

结构：CC(C)(C)OC(=O)NC(COCc1ccccc1)C(=O)ON1C(=O)CCC1=O

HCID333593

未命名化合物

HCID5287830

Purine, 6-bromo-

C5H3BrN4

HCID5356682

7H-Pyrrolo(2,3-d)pyrimidine, 4-chloro-

C6H4ClN3

结构：CCC(NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O

HCID12961228

未命名化合物

结构：CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(C)c2c(=O)n1-c1ccccc1

HCID178456854

未命名化合物

PRODUCTS

生成物

结构：Cc1cccc2nc(C(COCc3ccccc3)Nc3ncnc4[nH]ccc34)n(-c3ccccc3)c(=O)c12

HCID11591464

未命名化合物

PROCEDURE

实验过程

Compound 30 was prepared using the general procedure described above with respect to compound 14, but 3-benzyloxy-2-tert-butoxycarbonylaminopropionic acid 2,5-dioxo-pyrrolidin-1-yl ester was substituted for 2-benzyloxycarbonylaminobutyric acid 2,5-dioxo-pyrrolidin-1-yl ester in step B, the alternate procedure (TFA deprotection) was used in step C, and 4-chloro-7H-pyrrolo[2,3-d]pyrimidine was substituted for 6-bromopurine in step D. MS (ES): m/z 503 (M+H), 395. Compound 30is shown below.

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-1ec3fd36bbb14d649a6859fe5dfb8976
来源数据集: uspto-grants-2015_03
DOI: 10.6084/m9.figshare.5104873.v1
专利: US08980901B2
来源说明: uspto-grants-2015_03

反应 SMILES

[CH3:1][C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[C:4](=[O:31])[N:5]([C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)[C:6]([CH:12]([NH:15][C:16]1[N:24]=[CH:23][N:22]=[C:21]3[C:17]=1N=[CH:19][NH:20]3)[CH2:13]C)=[N:7]2.O=C1CCC(=O)N1OC(=O)C(NC(OC(C)(C)C)=O)C[O:43][CH2:44][C:45]1[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=1.O=[C:61]1CCC(=O)N1OC(=O)C(NC(OCC1C=CC=CC=1)=O)CC.C(O)(C(F)(F)F)=O.ClC1C2C=CNC=2N=CN=1.BrC1N=CN=C2C=1NC=N2>>[CH2:44]([O:43][CH2:13][CH:12]([C:6]1[N:5]([C:25]2[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=2)[C:4](=[O:31])[C:3]2[C:8](=[CH:9][CH:10]=[CH:11][C:2]=2[CH3:1])[N:7]=1)[NH:15][C:16]1[C:17]2[CH:61]=[CH:19][NH:20][C:21]=2[N:22]=[CH:23][N:24]=1)[C:45]1[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=1